Back to JNJView Full LandscapeView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
14 competitors in Multiple Myeloma
CELGiberdomide
BMYcilta-cel
DFPHCAR T Cell Therapy
BMYArlocabtagene Autoleucel
Phase 2INCYRuxolitinib 25 mg
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
levofloxacin, azithromycin, amoxicillin/clavulanatePhase 3
Bronchitis
VELCADE Administered by subcutaneous injectionPhase 3
Multiple Myeloma
Risperidone, oral tabletsPhase 3
Bipolar Disorders
risperidone oral tabletsPhase 3
Anxiety Disorders
Risperidone long-acting injectablePhase 3
Schizophrenia
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts